Cross-fund · 4 holders
DNA
GINKGO BIOWORKS HOLDINGS INC
CUSIP 37611X209
4
Tracked holders
$50.0M
Aggregate value
7,119,956
Shares
5
Active funds
Funds holding DNA
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $24.1M | — | +420,448 | +17.0% |
| BlackRock | Institutional | Q1 2026 | $22.3M | — | +68,978 | +1.9% |
| Millennium | Multi-Strategy | Q1 2026 | $3.0M | — | +439,056 | +897.8% |
| Citadel | Multi-Strategy | Q1 2026 | $543,731 | — | -119,930 | -57.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -76,908 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.